Axalbion

Private

ManchesterHealthcare & Life Scienceshttps://axalbion.com/

Last Round

Early Funding

Aug 27, 2024

Company Overview

Axalbion is a clinical-stage biopharmaceutical company developing novel medicines for the treatment of chronic cough.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalchronic coughTRPM8 agonistclinical-stage biotechrefractory chronic coughRCCUCCdrug developmentrespiratory healthclinical trialscough medicinesensory hypersensitivityfirst-in-class therapybiotech startuppharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axalbion Comps

Public and private peers based on sector, stage, and business model.

Axalbion comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Axalbion Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Aug 27, 2024

View all Funding Rounds

Axalbion Investors

Notable investors and investment history

Axalbion investors
Investor	Rounds
Perscitus LLP	Early Funding
EPFL Innovation Park	Early Funding

View all Investors

Axalbion Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Axalbion Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axalbion's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester

Employee Range6

Year Founded2016

Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.